Policy & Regulation The Chinese Academy of Sciences (CAS), China's top state research body, announced on 28 September 2026 that it had released its 15th Five-Year development plan covering 2026 to 2030. The plan lists brain-computer interfaces among its 'important priority fields' (重要优先领域), alongside integrated circuits, artificial intelligence, quantum science and technology, life sciences and biotechnology, and controlled nuclear fusion. CAS will organise research around a '3+4+X' regional layout with Shanghai as one of three strategic highlands, and will explore forming field-based research consortia, mission-based task forces and platform-based facility clusters across its institutes. CAS already runs its own invasive BCI programme: a system developed at its Shanghai Center for Excellence in Brain Science and Intelligence Technology (CEBSIT) was implanted in its first trial participant at Huashan Hospital in March 2025, and StairMed, founded by CEBSIT researcher Zhao Zhengtuo, entered the National Medical Products Administration's innovative device green channel in November 2025 with a market target of around 2028. CAS was one of the seven co-signatories of the 2025 BCI industry implementation opinions. The plan lands six days after Premier Li Qiang inspected BCI products in Shanghai and called future industries a blue ocean for advanced manufacturing. No BCI budget, programme names or milestones have been made public.
Sep 30